HighMark Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
HighMark Wealth Management's LLY Position: Q1 2026 in Review
HighMark Wealth Management increased its Eli Lilly (LLY) stake by 0.47% in Q1 2026, buying an estimated $8.11K and bringing the position to 1,728 shares worth $1.59M. The position accounts for 0.65% of the portfolio, ranked #24.
HighMark Wealth Management first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.01M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- HighMark Wealth Management held 1,728 shares of Eli Lilly worth $1.59M as of Q1 2026.
- HighMark Wealth Management bought 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
- Eli Lilly made up 0.65% of HighMark Wealth Management's portfolio in Q1 2026, its #24 holding.
- HighMark Wealth Management first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
- HighMark Wealth Management's Eli Lilly position peaked at $2.01M in Q2 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.